AbbVie to buy Landos Biopharma for $212M

0
238

As AbbVie charts its course towards bolstering its portfolio and advancing groundbreaking therapies, the acquisition of Landos Biopharma stands as a testament to its unwavering commitment to medical innovation and patient well-being.